{
    "organizations": [],
    "uuid": "2de274465602f0260974380f9bace3a6d4622eff",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ri-removes-sawai-pharmaceutical-fr/brief-ri-removes-sawai-pharmaceutical-from-rating-monitor-and-affirms-its-rating-at-a-ri-idUSL4N1RG2UQ",
    "ord_in_thread": 0,
    "title": "BRIEF-R&I removes Sawai Pharmaceutical from rating monitor and affirms its rating at A--R&I",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Sawai Pharmaceutical Co Ltd\n* Rating and Investment Information, Inc. (R&I) removed the company from rating monitor-R&I\n* Rating and Investment Information, Inc. (R&I) affirmed the company’s rating at “A-“-R&I\n* Rating outlook stable-R&I\nSource text in Japanese: goo.gl/dHxKrP\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-03T14:41:00.000+03:00",
    "crawled": "2018-04-04T12:23:30.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "sawai",
        "pharmaceutical",
        "co",
        "ltd",
        "rating",
        "investment",
        "information",
        "r",
        "removed",
        "company",
        "rating",
        "rating",
        "investment",
        "information",
        "r",
        "affirmed",
        "company",
        "rating",
        "rating",
        "outlook",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}